EA200601030A1 - 7α, 17α-SUBSTITUTED 11β-HALOGENOSTEROIDS, METHODS FOR THEIR RECEPTION, APPLICATION AND PHARMACEUTICAL PREPARATION ON THEIR BASIS - Google Patents

7α, 17α-SUBSTITUTED 11β-HALOGENOSTEROIDS, METHODS FOR THEIR RECEPTION, APPLICATION AND PHARMACEUTICAL PREPARATION ON THEIR BASIS

Info

Publication number
EA200601030A1
EA200601030A1 EA200601030A EA200601030A EA200601030A1 EA 200601030 A1 EA200601030 A1 EA 200601030A1 EA 200601030 A EA200601030 A EA 200601030A EA 200601030 A EA200601030 A EA 200601030A EA 200601030 A1 EA200601030 A1 EA 200601030A1
Authority
EA
Eurasian Patent Office
Prior art keywords
substituted
methods
pharmaceutical preparation
halogenosteroids
reception
Prior art date
Application number
EA200601030A
Other languages
Russian (ru)
Other versions
EA010572B1 (en
Inventor
Людвиг Цорн
Рольф Больманн
Норберт Галлус
Германн Кюнцер
Ханс-Петер Мун
Райнхард Нуббемейер
Original Assignee
Шеринг Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10233723A external-priority patent/DE10233723A1/en
Application filed by Шеринг Акциенгезельшафт filed Critical Шеринг Акциенгезельшафт
Publication of EA200601030A1 publication Critical patent/EA200601030A1/en
Publication of EA010572B1 publication Critical patent/EA010572B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating
    • C12P33/08—Hydroxylating at 11 position
    • C12P33/10—Hydroxylating at 11 position at 11 alpha-position
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/12—Acting on D ring
    • C12P33/16—Acting at 17 position

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

В заявке описываются новые соединения, представляющие собой 7α,17α-замещенные 11β-галогенстероиды общей формулы (8,10,12)способы их получения, применение и фармацевтический препарат на их основе.The application describes new compounds, which are 7α, 17α-substituted 11β-halogen steroids of the general formula (8,10,12), methods for their preparation, use and pharmaceutical preparation based on them.

EA200601030A 2002-07-24 2003-07-24 7 alpha, 17 alpha substituted 11 beta halogen steroids, processes for production thereof, use thereof and pharmaceutical preparation based thereon EA010572B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10233723A DE10233723A1 (en) 2002-07-24 2002-07-24 Preparation of 7 alpha-substituted 11 alpha-hydroxy-steroids, useful as precursors for new androgenic 7 alpha,17 alpha-substituted 11 beta-halo-steroids, by microbiological conversion of 7 alpha-substituted steroids
US40295302P 2002-08-14 2002-08-14

Publications (2)

Publication Number Publication Date
EA200601030A1 true EA200601030A1 (en) 2006-10-27
EA010572B1 EA010572B1 (en) 2008-10-30

Family

ID=31189296

Family Applications (2)

Application Number Title Priority Date Filing Date
EA200500224A EA008147B1 (en) 2002-07-24 2003-07-24 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
EA200601030A EA010572B1 (en) 2002-07-24 2003-07-24 7 alpha, 17 alpha substituted 11 beta halogen steroids, processes for production thereof, use thereof and pharmaceutical preparation based thereon

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA200500224A EA008147B1 (en) 2002-07-24 2003-07-24 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids

Country Status (20)

Country Link
EP (1) EP1523568A2 (en)
JP (1) JP4417838B2 (en)
KR (1) KR101041328B1 (en)
CN (1) CN100339486C (en)
BR (1) BR0313210A (en)
CA (1) CA2492079C (en)
CO (1) CO5690563A2 (en)
CR (1) CR7672A (en)
EA (2) EA008147B1 (en)
EC (1) ECSP055630A (en)
HK (1) HK1081999A1 (en)
HR (1) HRP20050172A2 (en)
IL (1) IL166358A0 (en)
MX (1) MXPA05001024A (en)
NO (1) NO20050980L (en)
NZ (2) NZ537871A (en)
PH (1) PH12005500143B1 (en)
PL (1) PL373808A1 (en)
RS (1) RS51855B (en)
WO (1) WO2004011663A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100982540B1 (en) * 2005-10-27 2010-09-16 다이호야쿠힌고교 가부시키가이샤 Process for production of steroid compound
CN103834712B (en) * 2012-11-26 2016-03-30 复旦大学 The optimization method of desogestrel intermediate nanometer liposome bio-transformation
CN103214543B (en) * 2012-12-25 2015-09-02 中国人民解放军海军医学研究所 New Crategolic acid derivative, its preparation method and the application in antitumor drug thereof
CN104862323B (en) * 2015-06-02 2018-01-16 中国农业科学院生物技术研究所 Modify the '-hydroxylase gene of diphenol compounds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE496261A (en) 1949-06-11
US2658023A (en) * 1953-04-21 1953-11-03 Pfizer & Co C Oxygenation of steroids
US2985563A (en) * 1958-11-13 1961-05-23 Schering Corp 11alpha-hydroxylation of steroids by glomerella
US3004047A (en) * 1959-03-13 1961-10-10 Olin Mathieson 6alpha-halo-11alpha-hydroxy steroids of the pregnane series and esters thereof
US3341557A (en) * 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3203869A (en) * 1962-10-11 1965-08-31 Syntex Corp 11alpha-hydroxylation of 6-substituted-11-desoxy steroids with microorganisms of thegenus fusarium, liseola section
US5342834A (en) 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
EP1167380A3 (en) * 1995-12-11 2004-12-08 G.D. Searle & Co. 11.alpha.-hydroxy-steroid-4,6-dien-3-one compounds and a process for their preparation
GB9525194D0 (en) 1995-12-12 1996-02-07 Zeneca Ltd Pharmaceutical composition
ES2175175T3 (en) 1995-12-12 2002-11-16 Akzo Nobel Nv A MICROBIAL METHOD FOR THE 11ALFA-HYDROXYLATION OF STEROIDS.
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
US5952319A (en) 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
JP2003522795A (en) 2000-02-15 2003-07-29 シェーリング アクティエンゲゼルシャフト Male contraceptive formulation consisting of norethisterone
DE10104327A1 (en) 2001-01-24 2002-07-25 Schering Ag New 11beta-halo-testosterone derivatives useful in male hormone replacement therapy and in male fertility control
CN1671394A (en) * 2002-07-25 2005-09-21 舍林股份公司 Composition containing an androgenous 11beta-halogen steroid and a progestational hormone, and male contraceptive based on said composition

Also Published As

Publication number Publication date
ECSP055630A (en) 2005-04-18
PH12005500143B1 (en) 2011-03-25
CN1671858A (en) 2005-09-21
NZ537871A (en) 2006-10-27
WO2004011663A2 (en) 2004-02-05
JP4417838B2 (en) 2010-02-17
EA200500224A1 (en) 2005-08-25
BR0313210A (en) 2005-06-28
PL373808A1 (en) 2005-09-19
AU2003281677A1 (en) 2004-02-16
HRP20050172A2 (en) 2005-04-30
MXPA05001024A (en) 2005-05-16
MX260952B (en) 2008-10-01
KR101041328B1 (en) 2011-06-14
EA010572B1 (en) 2008-10-30
CA2492079A1 (en) 2004-02-05
NZ549529A (en) 2008-04-30
EP1523568A2 (en) 2005-04-20
RS51855B (en) 2012-02-29
RS20050045A (en) 2007-06-04
IL166358A0 (en) 2006-01-16
KR20050026507A (en) 2005-03-15
EA008147B1 (en) 2007-04-27
JP2006503813A (en) 2006-02-02
NO20050980L (en) 2005-02-23
WO2004011663A3 (en) 2004-07-15
CN100339486C (en) 2007-09-26
HK1081999A1 (en) 2006-05-26
CA2492079C (en) 2012-01-10
CO5690563A2 (en) 2006-10-31
WO2004011663A9 (en) 2004-05-06
CR7672A (en) 2006-05-29

Similar Documents

Publication Publication Date Title
EA200700225A1 (en) TETRAPTIDE ANALOGUES
SE0301700D0 (en) Novel compounds
WO2003095455A3 (en) Substituted pyrazolopyrimidines
WO2005046603A3 (en) Pyridine compounds
CY1109998T1 (en) GLUTAMINIC RECEPTORS HARMONIZERS
DK1656372T3 (en) 2,4-PYRIMIDINE DIAMINE COMPOUNDS FOR USING TREATMENT OR PREVENTION OF AUTO-IMMUNE DISEASES
EA200401169A1 (en) AMINOMETHYL SUBSTITUTED TETRACYCLINE COMPOUNDS
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MX337423B (en) Humanized anti-beta7 antagonists and uses therefor.
AU2002341920A1 (en) Chemical compounds
PL1613598T3 (en) Methods of preparing aripiprazole crystalline forms
BRPI0312649A2 (en) compounds, pharmaceutical compositions containing them, and processes of use therefor.
SE0301653D0 (en) Novel compounds
NO20054535L (en) Bifunctional heterocyclic compounds and processes for the preparation and use of the same
SE0302139D0 (en) Novel compounds
NO20043016L (en) 6-aminomorphinan derivatives, process for preparation and use thereof
EA200700550A1 (en) DERIVATIVES OF ALKYLIDENTETRAHYDRONAPTALINE, METHOD OF THEIR RECEIVING AND THEIR APPLICATION AS ANTI-INFLAMMATORY MEANS
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
WO2005054172A3 (en) Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof
MY138479A (en) 7alpha-hydroxyacetyl and 7alpha-hydroperoxyacetyl-substituted steroid compounds
MX2007004461A (en) Pharmaceutical compositions based on nk2 antagonists for pediatric use.
EA200601030A1 (en) 7α, 17α-SUBSTITUTED 11β-HALOGENOSTEROIDS, METHODS FOR THEIR RECEPTION, APPLICATION AND PHARMACEUTICAL PREPARATION ON THEIR BASIS
WO2004050613A3 (en) 2-substituted-3-propenamide derivatives and methods of using the same
ATE274515T1 (en) PYRAZOLOPYRIDINE DERIVATIVES
DK1406927T3 (en) Glycopeptides, Preparation and Use thereof for Diagnosis or Therapeutic Treatment of Disseminated Sclerosis

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU